NEW YORK – HealthReveal will use $10.8 million in Series A funding to continue developing its predictive analytics solution for providers, payers and employers. “HealthReveal is building an analytical bridge between the medical literature and covered individuals’ phenotypic clinical profiles, generating diagnostic and treatment guidance in line with current medical best practice,” said Dr. Lonny Reisman, CEO and founder of HealthReveal, in a statement. “Our company is founded on the simple principle that knowledge saves lives and that by looking at each patient personally and comprehensively we can make a meaningful improvement in clinical outcomes, medical costs and value.” The HealthReveal solution continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients. When data suggest that the patient’s care has deviated from those guidelines, HealthReveal suggests immediate and highly personalized interventions to optimize care and reduce the risk of adverse medical events.
You are here: / / HealthReveal raises $10.8M for clinical analytics solution